Replies to post #133409 on OWC Pharmaceutical Research Corp (OWCP)

[EasternTimeZone]

Hang in there brighter days are coming. My opinion of course, but according to the SEC Jeffery Friedland was selling 6.4 million shares during the few months that we suffered the decline. He didn't do his job well, we all saw that, and I would guess that word got out by his associates in Colorado which may have emboldened shorts and MM manipulation.

Anyway, the snake in the grass is outed and OWC has made real progress with their team during 2017 as well as the partnership with mediq and the patent that was awarded.


The fundamentals of the company are as strong as ever and they are making progress. Innovative medical research takes time. OWC has focused in on a two-pronged approach to developing products in over-the-counter markets and prescription markets.

I see a big improvement in the way OWCP communicates with us shareholders since Dr. Stanley Hirsch became Chairman of our Board of Directors in July 2017.


I'm $OWCP Long and Strong

[MjMilo]

I feel your pain..I have six figures invested and am down almost 80%.

You have to do what's right for your situation but I can tell you I am not selling one share because nothing has fundamentally changed with the company.

And this statement is good enough for me:

OWC Pharmaceutical Research Corp. Issues Chairman's Statement to Shareholders
Thursday, March 08, 2018, 10:31 AM ET

PETACH TIKVA, Israel, March 8, 2018 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today issued a chairman's statement to shareholders.
In the light of recent events, and the numerous communications we have received from shareholders, I would like to address this statement to the Shareholders of OWCP (the "Company").
The Company is committed to building a leadership position in the medical cannabis market and to our mission of improving patients' lives through the development of new solutions, products and devices derived from and delivery mechanisms for the use of medical cannabis.
We have recruited a highly skilled management team with multi-year experience in medical cannabis, pharmaceutical development, corporate management and capital markets.
As we have stated in our 8-K filing of today, we are neither a party to the pending SEC action against a former adviser to the Company, nor is the Company alleged to have been a party to nor had any knowledge of the purported scheme by the former adviser, who is the subject of the SEC action.
The Company's management is committed to and focused on our development programs which are continuing as per plan. These include inter alia, our current safety trial for our cannabis cream; the approval processes to initiate a safety trial for our oral disintegrating tablet and additional pipeline projects.
As a management team, we are committed to building value for our shareholders though professional, ethical and strategic management of a technology platform that we believe will bring improved health and quality of life to millions of patients around the world. We have recently announced the addition of our new Chief Scientific Officer and we continue to develop the resources we believe will bolster our endeavors in creating a great company.
Yours sincerely,
Dr. Stanley Hirsch
Chairman of the Board

[zombywolf]

Joe, there is more to this story. We have only heard from the SEC, not the other side. While the SEC charges appear legit vs Jeffee, he hasnt talked to them yet from the complaint. Dont always believe what you hear from the company. This is the same company that sued their law firm for negligence in not informing them of a financial default date, when they published the date in an 8k prior to the default. This is not an indictment of now, but more so of the operations when Jeffee's caper occurred.